Morphisec, Ltd.

Morphisec, Ltd. , based in BeerSheba, Israel, is a technology company specializing in advanced endpoint security solutions that protect organizations from cyber threats, particularly ransomware attacks. Founded in 2014 in BeerSheba, Israel, Morphisec, Ltd. develops innovative cybersecurity solutions.

The company has successfully raised a total of USD 31 mn in funding, with its most recent deal occurring on March 25, 2021, led by Jerusalem Venture Partners and including investors such as Deutsche Telekom Capital Partners and Orange Ventures. The company was co-founded by Dudu Mimran and Yuval Elovici, with Ronen Yehoshua serving as CEO. Morphisec specializes in endpoint security and threat prevention, primarily through its patented Automated Moving Target Defense (AMTD) technology. Their flagship offering, the Anti-Ransomware Assurance Suite, provides multi-layered protection designed to preemptively prevent ransomware attacks at the endpoint level.

By leveraging runtime memory protection, Morphisec's solutions address various advanced threats, including data encryption, credential theft, and system recovery tampering, effectively filling the gaps left by traditional solutions like next-generation antivirus (NGAV) and endpoint detection and response (EDR) systems. The company serves a diverse clientele across finance, healthcare, manufacturing, and technology sectors, with notable customers like TruGreen and Houston Eye Associates. Morphisec's products are marketed primarily in North America, Europe, and parts of Asia, catering to organizations seeking to enhance their cybersecurity posture against evolving threats. Morphisec generates revenue through a subscription-based model, offering its cybersecurity solutions to businesses on an annual or multi-year basis.

Organizations enter direct agreements to pay for licenses enabling the deployment of Morphisec's software across their endpoints. The pricing plans are flexible, accommodating various organizational sizes and needs, which may include bundled services enhancing core offerings. The Anti-Ransomware Assurance Suite is strategically positioned as a comprehensive solution for clients aiming to mitigate risks associated with ransomware attacks, aligning with security teams' operational requirements. Through these structured agreements, Morphisec fosters long-term relationships with its clients, ensuring continuous support and updates to adapt to the dynamic cybersecurity landscape.

In March 2021, Morphisec, Ltd. raised USD 31 mn in venture funding to support a major hiring campaign in the US and Israel. The company plans to leverage this funding to expand its workforce to accelerate product development and enhance market presence. Future initiatives may include the introduction of new cybersecurity products aimed at addressing evolving threats and exploring expansion opportunities into new markets and regions.

Specific targeted markets for expansion have not been disclosed, but the company aims to solidify its position in the global cybersecurity landscape.